We are live on ! Find out more
ACW

Accuride Corp
ACW

Delisted

ACW was delisted on the 17th of November, 2016.

96 hedge funds and large institutions have $140M invested in Accuride Corp in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

857% more call options, than puts

Call options by funds: $67K | Put options by funds: $7K

18% more capital invested

Capital invested by funds: $118M → $140M (+$21.3M)

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

12% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 33

0% more funds holding

Funds holding: 9696 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
96
Holders Change
Holders Change %
0%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
15
Increased
37
Reduced
33
Closed
13
Calls
$67K
Puts
$7K
Net Calls
+$60K
Net Calls Change
-$34K
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$101K
M&T Bank
77
M&T Bank
New York
$91K -$21.5K -4,780 -19%
T. Rowe Price Associates
78
T. Rowe Price Associates
Maryland
$85K
Connor, Clark & Lunn Investment Management (CC&L)
79
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$71K +$451 +100 +0.6%
MC
80
Menta Capital
California
$68K -$80.7K -17,896 -53%
DTL
81
Dynamic Technology Lab
Singapore
$65K -$13.3K -2,942 -17%
VKH
82
Virtu KCG Holdings
New York
$60K +$62.4K +13,840 New
Susquehanna International Group
83
Susquehanna International Group
Pennsylvania
$57K +$59.2K +13,139 New
MA
84
MUFG Americas
New York
$46K +$18.9K +4,200 +65%
Barclays
85
Barclays
United Kingdom
$23K -$64.1K -14,219 -71%
TRCT
86
Tower Research Capital (TRC)
New York
$19K -$279 -62 -1%
TDC
87
Thompson Davis & Co
Virginia
$17K -$4.51K -1,000 -20%
Bank of America
88
Bank of America
North Carolina
$10K -$15.4K -3,425 -60%
Wells Fargo
89
Wells Fargo
California
$8K +$63 +14 +0.8%
Parallax Volatility Advisers
90
Parallax Volatility Advisers
California
$7K +$7.66K +1,700 New
BlackRock
91
BlackRock
New York
$6K
MTIP
92
Magee Thomson Investment Partners
California
$5K -$343 -76 -7%
Acadian Asset Management
93
Acadian Asset Management
Massachusetts
$4K +$4.51K +1,000 New
WA
94
WFG Advisors
Texas
$1K
Bank of Montreal
95
Bank of Montreal
Ontario, Canada
$1K +$1.19K +264 New
Manulife (Manufacturers Life Insurance)
96
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$119 +$8.37K +1,857 +7%
T
97
Tahithromos
New York
-$2.07M -547,165 Closed
YCMGA
98
York Capital Management Global Advisors
New York
-$948K -250,000 Closed
Verition Fund Management
99
Verition Fund Management
Connecticut
-$164K -43,160 Closed
ProShare Advisors
100
ProShare Advisors
Maryland
-$58K -15,276 Closed

ACW Hedge Fund Activity: Q4 2014 in Review

96 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Accuride Corp (ACW) for Q4 2014, worth a combined $140M — up 18% from $118M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ACW positions and 13 closed out — a net gain of 2 holders — while 37 added to existing stakes and 33 trimmed.

The largest buyer was Systematic Financial Management, adding an estimated $3.36M. The largest seller was Tahithromos, exiting entirely with an estimated $2.07M sold.

  • 96 institutional investors held Accuride Corp (ACW) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $140M of Accuride Corp stock for Q4 2014, up 18% quarter-over-quarter.
  • 15 funds opened new Accuride Corp positions in Q4 2014 and 13 closed out, a net change of +2 holders.
  • The largest Accuride Corp buyer in Q4 2014 was Systematic Financial Management, an estimated $3.36M added.
  • The largest Accuride Corp seller in Q4 2014 was Tahithromos, an estimated $2.07M sold.

Based on aggregated 13F filings for Q4 2014.